140 related articles for article (PubMed ID: 17689884)
1. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.
Peters CA; Stock RG; Cesaretti JA; Atencio DP; Peters S; Burri RJ; Stone NN; Ostrer H; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):752-9. PubMed ID: 17689884
[TBL] [Abstract][Full Text] [Related]
2. TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759).
Langsenlehner T; Kapp KS; Langsenlehner U
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):960; author reply 960-1. PubMed ID: 18514790
[No Abstract] [Full Text] [Related]
3. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
[TBL] [Abstract][Full Text] [Related]
5. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
6. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
[TBL] [Abstract][Full Text] [Related]
7. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
8. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.
Crook J; Esche B; Futter N
Urology; 1996 Mar; 47(3):387-94. PubMed ID: 8633407
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
[TBL] [Abstract][Full Text] [Related]
10. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
11. 10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy.
Berg A; Lilleby W; Bruland OS; Fosså SD
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1074-83. PubMed ID: 17703896
[TBL] [Abstract][Full Text] [Related]
12. Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene.
De Langhe S; De Ruyck K; Ost P; Fonteyne V; Werbrouck J; De Meerleer G; De Neve W; Thierens H
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):393-9. PubMed ID: 22658438
[TBL] [Abstract][Full Text] [Related]
13. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
Zelefsky MJ; Levin EJ; Hunt M; Yamada Y; Shippy AM; Jackson A; Amols HI
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1124-9. PubMed ID: 18313526
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer--a matched-pair comparison.
Pinkawa M; Asadpour B; Piroth MD; Gagel B; Nussen S; Kehl M; Borchers H; Jakse G; Eble MJ
Radiother Oncol; 2009 May; 91(2):225-31. PubMed ID: 19081154
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
King CR; Brooks JD; Gill H; Pawlicki T; Cotrutz C; Presti JC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1043-8. PubMed ID: 18755555
[TBL] [Abstract][Full Text] [Related]
16. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer.
Cesaretti JA; Stock RG; Lehrer S; Atencio DA; Bernstein JL; Stone NN; Wallenstein S; Green S; Loeb K; Kollmeier M; Smith M; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):196-202. PubMed ID: 15629612
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
18. A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2008 Jul; 38(7):480-5. PubMed ID: 18621847
[TBL] [Abstract][Full Text] [Related]
19. Erectile aid use by men treated for localized prostate cancer.
Bergman J; Gore JL; Penson DF; Kwan L; Litwin MS
J Urol; 2009 Aug; 182(2):649-54. PubMed ID: 19535108
[TBL] [Abstract][Full Text] [Related]
20. Influence of multiple genetic polymorphisms on genitourinary morbidity after carbon ion radiotherapy for prostate cancer.
Suga T; Iwakawa M; Tsuji H; Ishikawa H; Oda E; Noda S; Otsuka Y; Ishikawa A; Ishikawa K; Shimazaki J; Mizoe JE; Tsujii H; Imai T
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):808-13. PubMed ID: 18374504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
